NCT07075796Completed
Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
This study is a prospective, single center, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE in patients with diabetes type 2 and how the accuracy of the system improves as the time of use by the patient increases.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 10 Jul 2025
- Start date
- 2 Jun 2025
- Primary completion date
- 28 Nov 2025
- Lead sponsor
- iGluco
- Diseases
- Type 2 diabetes
- NCT number
- NCT07075796
What you commit to
- Study type: Interventional
- Participants enrolled: 52
- From 2 Jun 2025 to the primary completion date, 28 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient is currently participating in another clinical investigation or has participated in another clinical investigation in the last 30 days prior to the start of this study.
Other illness
- Presence of other anatomical or comorbid conditions, or other medical, social or psychological conditions that, in the opinion of the investigator, could limit the subject's ability to participate in the clinical investigation or to comply with the follow-up requirements, or affect the scientific soundness of the clinical investigation results.
- Patients with any active and/or infectious acute illness.
- Patients who have a condition that affects blood circulation in the fingers of the hand, such as Raynaud's phenomenon.
- Any medical condition that, in the opinion of the investigator, will increase the risk of hyperglycemic and hypoglycemic events: seizures, heart disease, unconscious hypoglycemia, etc.
- Patients with an inability to maintain hand stability during measurement or with progressive nervous system disease affecting movement (Parkinson's disease, moderate-severe essential tremor, and other diseases with involuntary movements).
Other
- Pregnant or breast-feeding women and those subjects who plan pregnancy during the clinical investigation follow-up period.
- Patients suffering from calluses, malformations, or open wounds with bandages on their hands.
- Patients with nail polish or any type of false nail.
Who the study is looking for
- Be ≥ 18 years of age.
- Diagnosed with type 2 diabetes mellitus.
- Have a smartphone with an internet connection that allows the installation of the GLUCUBE APP.
- Be able to use the GLUCUBE system autonomously, in the opinion of the researcher.
- Have signed the informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centro de Especialidades Virgen de los Reyes. Hospital Universitario Virgen del Rocío Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.